It is a typo. You pulled the info from a newswire press release from January 2012 and/or the Regenastem website. I did my DD and actually made a few phone calls to verify the typo and their status as plaintiffs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.